Searched for
MEROPENEM
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- IIT Roorkee scientists reveal how this common herb could defeat world’s most dangerous superbugs & enhance antibiotic powerIIT Roorkee researchers have discovered that thymol, a natural compound in thyme, can weaken antibiotic-resistant superbugs. The study reve...
- Antibiotics becoming ineffective against diseases like typhoid, pneumonia, and urinary infections: ICMR rings alarmA recent ICMR report highlights a troubling rise in antibiotic resistance in India. Diseases like UTIs, blood infections, pneumonia, and ty...
- Telangana government fixes ceiling on rates chargeable by private hospitals for COVID-19 treatmentThe inclusions in the three categories of treatmentare monitoring and investigations like CBC, Urine routine, HIV spot, Anti HCV, Serum Cre...
- Daylight robbery: Private hospitals prescribing medicines worth Rs 15,200 despite a Rs 800 alternative being availableOne of the main reasons behind this fleecing is that the more expensive the drug, the more profit the hospital makes on retail margins.
- Drug firm Venus Remedies gets nod to market generic meropenem in SwitzerlandThe company has received marketing authorisation from Swiss drug authority 'Swissmedic' through its German arm Venus Pharma GmbH for merope...
- Venus Remedies eyes $15 million from antibiotic meropenem; ties up with drug maker-MylanDeal with Mylan will enable Venus to market meropenem in Denmark, Sweden & Finland for a period of five years with estimated revenue of $1....
- Venus eyes $ 15 million from meropenem; ties up with MylanCurrently, Panchkula based drug major is selling meropenem in 35 countries which also includes regulated markets with revenue of $ 10 milli...
- Venus Remedies shares up as unit enters into pact with MylanIn terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the d...
- Venus Pharma ties up with Mylan for marketing of antibiotic MeropenemThe deal with Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for a period of five years.
- Venus Remedies to sell Meropenem in Australia; ties up with LupinVenus Remedies said it plans to roll out the drug by the third quarter of 2014 and is eyeing sizeable share in Australia's USD 15 million M...
- Venezuela okays marketing rights for meropenem to Venus RemediesVenus Remedies has received marketing authorisation for meropenem, an antibiotic drug, from Venezu in next few months and plans its launch ...
- Venus Remedies gets approval from Saudi Food and Drug Authority for 'meropenem'Claiming that Venus Remedies was the first to company to get such approval, it said it plans to launch this product in Saudi Arabia early n...
- Venus Remedies set to tap Italian market with antibiotic drugBeing an important member state of the European Union (EU), Italy has immense potential for meropenem, he added.
- Venus Pharma gets marketing authorisation nod from FranceVenus Pharma GmbH said it has got marketing authorisation (MA) approval from France for meropenem, a generic broad spectrum antibiotic inje...
- Venus Remedies gets market authorisation in Mexico for MeropenemThe Panchkula based company plans to launch the drug in 500 mg and 1,000 mg strengths in Mexico, Venus Remedies said in a release.
- Venus Remedies gets nod from UK, New Zealand for antibiotic drugVenus received approvals from health authorities in the UK and New Zealand for marketing its generic injectable antibiotic Meropenem
Load More
